UNSPSC 51201654: COVID19 - Moderna

A mRNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles.

UNSPSC 51201654 COVID19 - Moderna is a Commodity code that state and local health agencies use to procure vaccines, though recent activity shows scope drift from the code's nominal name. The Mississippi State Department of Health posted a sole source procurement notice in July 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., signaling that state health departments classify vaccine acquisitions under this code regardless of the specific product name. State and local vaccine procurement typically moves through health departments rather than broader purchasing consortia, and sole source notices—which invite objections to single-vendor designation before award—are common when health agencies claim exclusive availability or medical necessity. The code appears to capture routine immunization supply chain activity at the state level, though the mismatch between the code's COVID-19 Moderna label and actual buying activity (yellow fever vaccine from a non-Moderna supplier) suggests the taxonomy may not be actively refreshed for real-world procurement practice.

The sole source notice from Mississippi State Department of Health, with objections due August 3, 2026, is the only recent state or local opportunity supporting this code in the source. No dollar value, volume, or contract term is disclosed in the notice. Geographic spread and issuing-body concentration cannot be characterized from a single opportunity. Vendors or purchasing professionals tracking vaccine procurement at the state health-department level should monitor sole source and competitive bid activity from state boards of health, but this code shows minimal recent visibility compared to broader medical supply and pharmaceutical UNSPSC families that may better reflect actual state and local vaccine purchasing patterns.